Share on StockTwits

Solazyme (NASDAQ:SZYM) Director Michael V. Arbige unloaded 1,000 shares of the company’s stock in a transaction dated Monday, June 16th. The shares were sold at an average price of $11.34, for a total value of $11,340.00. Following the sale, the director now directly owns 132,787 shares of the company’s stock, valued at approximately $1,505,805. The transaction was disclosed in a document filed with the SEC, which is available at this link.

A number of analysts have recently weighed in on SZYM shares. Analysts at Morgan Stanley reiterated an “overweight” rating on shares of Solazyme in a research note on Friday, May 30th. They now have a $15.00 price target on the stock. Separately, analysts at Credit Suisse cut their price target on shares of Solazyme from $12.00 to $11.00 in a research note on Wednesday, April 2nd. Finally, analysts at Cowen and Company raised their price target on shares of Solazyme from $17.00 to $18.00 in a research note on Tuesday, April 1st. One analyst has rated the stock with a sell rating, one has assigned a hold rating and two have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $15.00.

Solazyme (NASDAQ:SZYM) opened at 12.22 on Wednesday. Solazyme has a 1-year low of $8.00 and a 1-year high of $15.00. The stock has a 50-day moving average of $10.07 and a 200-day moving average of $10.87. The company’s market cap is $928.4 million.

Solazyme (NASDAQ:SZYM) last announced its earnings results on Monday, May 5th. The company reported ($0.44) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.33) by $0.11. The company had revenue of $12.40 million for the quarter, compared to the consensus estimate of $14.63 million. During the same quarter in the previous year, the company posted ($0.43) earnings per share. The company’s revenue for the quarter was up 85.1% on a year-over-year basis. On average, analysts predict that Solazyme will post $-1.56 earnings per share for the current fiscal year.

Solazyme, Inc operates as a renewable oil production company. The Company fuels include microbial-derived jet fuels, bio-diesels, and renewable diesels.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.